Employers and health systems can do a better job of serving the specific healthcare needs of Millennials and Gen Zers by embracing the following seven approaches: 1) Enlist AI in the design of benefits and the delivery of care; 2) Harness virtual technologies to boost employees' engagement in choosing and making the most of their healthcare benefits; 3) Shift to prepayment reimbursement models, which emphasize maintaining patients' health rather than generating revenue when patients become ill; 4) Train physicians to connect with younger patients both technologically and culturally; 5) Combat the physician shortage by supporting educational programs and advocating for legislation to increase residency slots; 6) Treat mental health as an essential part of overall health; and 7) Adopting ways to make care for younger workers more affordable....

The Food and Drug Administration is seeking to drastically change procedures for testing vaccine safety and approving vaccines, based on unproven claims that mRNA-based COVID-19 vaccines caused the death of at least 10 children. Citing an internal, unpublished review, the memo, written by the agency's top vaccine regulator, Vinay Prasad, attributes the children's deaths to myocarditis, an inflammation of the heart muscle. And it says the deaths were reported to the Vaccine Adverse Event Reporting System, or VAERS, but provides no evidence that the vaccines caused the deaths. The death of children due to an unsafe vaccine is a serious allegation. I am a pediatric cardiologist who has studied the link between COVID-19 vaccines and heart-related side effects such as myocarditis in children. To my knowledge, studies to date have shown such side effects are rare, and severe outcomes even more so. However, I am open to new evidence that could change my mind. But without sufficient justification and solid evidence, restricting access to an approved vaccine and changing well-established procedures for testing vaccines would carry serious consequences. These moves would limit access for patients, create roadblocks for companies and worsen distrust in vaccines and public health....

The new vehicle focuses on small and mid-sized companies across technology, business services, and healthcare. It sits alongside Axcel's larger mid-market funds and widens the firm's coverage across Northern Europe. Most commitments came from returning LPs, including pension funds, funds of funds, foundations, and family offices. 'Investor interest in Axcel Elevate has exceeded our expectations, and we're grateful for the continued trust placed in our team,' said Christian Schmidt-Jacobsen, Co-Managing Partner at Axcel and Head of Elevate. Co-Managing Partner Christian Bamberger Bro added that the fund broadens Axcel's ability to cover the full market spectrum. Elevate follows Axcel VII, which closed oversubscribed at '1.3bn in 2023. The Elevate team will be led by Schmidt-Jacobsen, who will shift from Managing Partner to Partner with responsibility for the strategy during the firm's leadership transition in 2026, when Bamberger Bro becomes Managing Partner. Axcel has strengthened the team ahead of the investment period. Swedish Partner Johan Lunden will join in spring 2026 after roles at Trill Impact and Nordic Capital. Partners Kasper Olesen and Jacob Drakenberg Walberg, both long-standing Axcel professionals, will also support deployment....

When budgets tighten, programs that promote psychological safety'the freedom to speak up without fear of retribution'are often cut. New research shows that's a mistake. A study of 27,000 healthcare workers during the pandemic found that feeling psychologically safe significantly reduces burnout and turnover, even when resources are severely constrained. Employees who felt safe enough to voice concerns also proved to be more resilient and more likely to stay in their jobs. Building this 'social resource' before a crisis pays dividends when uncertainty spikes....